Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information on how we use and manage cookies please take a look at our privacy and cookie policies. Some parts of the site may not work properly if you choose not to accept cookies.

sections
Home > QuantumMethod > Pharma is Moving to Digital & Social Media. Wake up!
 

Pharma is Moving to Digital & Social Media. Wake up!

White Paper Published By: QuantumMethod
QuantumMethod
Published:  Jul 28, 2011
Type:  White Paper
Length:  4 pages

It's happening right now, all around us. Some of it is under the radar, some of it right out in the open. In spite of the cries for FDA guidance, which seems like it will never come, or fears of being the first to jump off the proverbial cliff, big Pharma is slowly making the move that mainstream consumer brands took years ago. The likes of Lilly, Pfizer, J&J, and Sanofi-Aventis are moving more and more marketing dollars to digital media and away from traditional DTC. There are many factors moving brand managers in this direction. These forces have been pushing and shoving at them for years now, and in many cases it comes down to simple physics - you simply cannot resist market forces forever, something has to give. Consumers are on a mass move from traditional media consumption to multi-platform digital and social media - or what some will simply call "new media."



Tags : 
digital, pharma, social media, advertising, fda, brand, consumer, drug